HIMS HERS HEALTH INC

NYSE: HIMS (Hims & Hers Health, Inc.)

Last update: 01 Jun, 8:47AM

56.56

4.16 (7.94%)

Previous Close 52.40
Open 52.27
Volume 40,902,380
Avg. Volume (3M) 35,219,219
Market Cap 12,659,938,304
Price / Earnings (TTM) 83.18
Price / Earnings (Forward) 95.24
Price / Sales 7.78
Price / Book 23.46
52 Weeks Range
13.47 (-76%) — 72.98 (29%)
Earnings Date 4 Aug 2025
Profit Margin 8.54%
Operating Margin (TTM) 4.69%
Diluted EPS (TTM) 0.530
Quarterly Revenue Growth (YOY) 95.10%
Quarterly Earnings Growth (YOY) 1,990.40%
Total Debt/Equity (MRQ) 2.38%
Current Ratio (MRQ) 1.79
Operating Cash Flow (TTM) 251.08 M
Levered Free Cash Flow (TTM) 178.69 M
Return on Assets (TTM) 7.18%
Return on Equity (TTM) 30.71%

Market Trend

Short Term Medium Term
Industry Household & Personal Products (US) Bearish Bearish
Household & Personal Products (Global) Bearish Bearish
Stock Hims & Hers Health, Inc. Bearish Bullish

AIStockmoo Score

-0.6
Analyst Consensus -3.5
Insider Activity -3.0
Price Volatility -3.0
Technical Moving Averages 2.5
Technical Oscillators 4.0
Average -0.60

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
HIMS 13 B - 83.18 23.46
ELF 7 B - 65.24 9.27
PG 385 B 1.84% 26.03 7.47
UL 157 B 2.23% 24.65 6.68
CL 75 B 1.66% 25.57 205.82
KVUE 45 B 2.57% 43.71 4.17

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

Sector Consumer Defensive
Industry Household & Personal Products
Investment Style Small Growth
% Held by Insiders 11.30%
% Held by Institutions 79.74%
52 Weeks Range
13.47 (-76%) — 72.98 (29%)
Price Target Range
26.00 (-54%) — 65.00 (14%)
High 65.00 (Needham, 14.92%) Buy
Median 33.00 (-41.66%)
Low 26.00 (B of A Securities, -54.03%) Sell
Average 37.57 (-33.58%)
Total 1 Buy, 4 Hold, 2 Sell
Avg. Price @ Call 43.86
Firm Date Target Price Call Price @ Call
Morgan Stanley 11 Jun 2025 40.00 (-29.28%) Hold 57.56
29 Apr 2025 40.00 (-29.28%) Hold 35.04
Needham 04 Jun 2025 65.00 (14.92%) Buy 53.61
06 May 2025 61.00 (7.85%) Buy 49.47
Citigroup 06 May 2025 30.00 (-46.96%) Sell 49.47
25 Apr 2025 25.00 (-55.80%) Sell 28.09
Piper Sandler 06 May 2025 39.00 (-31.05%) Hold 49.47
B of A Securities 29 Apr 2025 26.00 (-54.03%) Sell 35.04
18 Mar 2025 22.00 (-61.10%) Sell 31.49
TD Cowen 29 Apr 2025 30.00 (-46.96%) Hold 35.04
Truist Securities 10 Apr 2025 33.00 (-41.65%) Hold 26.81
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
CHI MICHAEL - 56.33 -5,100 -287,283
Aggregate Net Quantity -5,100
Aggregate Net Value ($) -287,283
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 56.33
Name Holder Date Type Quantity Price Value ($)
CHI MICHAEL Officer 06 Jun 2025 Automatic sell (-) 5,100 56.33 287,283
CHI MICHAEL Officer 06 Jun 2025 Option execute 5,100 - -
CHI MICHAEL Officer 05 Jun 2025 Option execute 28,776 - -
Date Type Details
03 Jun 2025 Announcement Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
03 Jun 2025 CNBC Hims & Hers to acquire European telehealth platform in global expansion
22 May 2025 Announcement Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
08 May 2025 Announcement Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
08 May 2025 Announcement Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
08 May 2025 Announcement Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
05 May 2025 Announcement Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
05 May 2025 Announcement Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
29 Apr 2025 Announcement Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
29 Apr 2025 CNBC Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%
25 Apr 2025 CNBC Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
14 Apr 2025 Announcement Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
22 Mar 2025 CNBC Zepbound copycats remain online despite FDA ban
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria